Bioxytran, Inc. (BIXT)
OTCMKTS
· Delayed Price · Currency is USD
0.0827
+0.0091 (12.36%)
Feb 21, 2025, 3:37 PM EST
Bioxytran Employees
Bioxytran had 3 employees as of December 31, 2023. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$900,208
Market Cap
7.29M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 2,931 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 413 |
| CytoDyn | 9 |
| Northwest Biotherapeutics | 25 |
| SANUWAVE Health | 31 |
| Silence Therapeutics | 109 |
Bioxytran News
- 6 weeks ago - Bioxytran's Cancer Preprint Reveals Potential to Enhance Most Immunotherapy Drugs - GlobeNewsWire
- 5 months ago - Bioxytran's Medical Breakthrough in Fighting All Viruses - Accesswire
- 6 months ago - Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now - GlobeNewsWire
- 7 months ago - Bioxytran Launches Joint Venture with the Heme Foundation for Development of Universal Oxygen Carrier - GlobeNewsWire
- 8 months ago - Bioxytran's Advisor Releases Book on Hyperbaric Oxygenation Related to Stroke & Alzheimer's Patients - GlobeNewsWire
- 1 year ago - Bioxytran Announces Preprint of Shingles Case Study Showing Clearance Using a Topical Galectin-3 Antagonist - GlobeNewsWire
- 1 year ago - Bioxytran's Oral Antiviral Drug to Enter Dose Optimization Clinical Trial for COVID-19 - GlobeNewsWire
- 1 year ago - Bioxytran Gets Broad Patent Coverage on 60+ Viruses - GlobeNewsWire